Summary Desmoids are locally aggressive. non-metastasizing soft-tissue tumours. whose aetiology is still unclear. In patients affected with familial adenomatous polyposis (FAP), the incidence of desmoids is much higher than in the general population. The 
proliferations that do not metastasize. even if thev have a marked tendency towards local invasion and a si1nificant risk of recurrence. The neoplastic nature of desmoids has recently been assessed by molecular studies. w hich demonstrated that these pathological entities are indeed clonal processes (Li et al. 1996 : Alman et al. 1997a : Lucas et al. 1997 . Whereas desmoids are rare in the general population. representing less than 0.1 % of all human tumours. with an incidence of 2-4 cases per million per year (Pack and Ehrlich. 1944 : Reitamo et al. 1986 ). they occur with elevated incidence (8-12%,-) in patients affected wmith familial adenomatous polyposis (FAP) (Jones et al. 1986 . Gurbuz et al. 1994 . FAP is an autosomal dominant genetic condition. characterized by the development of hundreds to thousands of colorectal adenomas (polyps.) which almost in ariablv lead to carcinomas. if prophylactic colectomy is not performed (Bussey. 1975) . This sxndrome may be considered as a growth disorder affecting multiple body sites. being characterized bx the occurrence. in addition to colorectal polyps. of a varietx of extracolonic lesions. including thyroid and adrenocortical tumours. epidermoid cysts. osteomas and desmoid tumours (Campbell et al. 1994) . The latter predominantly occur intraabdominaliv or in the abdominal wall. usually after surgerx (Jones et al. 1986 : Gurbuz et al. 1994 . and represent an important cause of morbiditv and mortality in FAP (Clark and Phillips. 1996) .
The gene responsible for FAP. termed APC for adenomatous poliposis coli. maps to the long arm of chromosome 5 (q2l-22) and was isolated in 1991 (Groden et al. 1991 : Joslvn et al. 1991 : Kinzler et al. 1991 : Nishisho et al. 1991 .
In addition to Lermline mutations in individuals affected S ith FAP. somatic inactivating mutations of the APC gene has-e been identified in a high proportion of colorectal adenomas and carcinomas. both in FAP patients and sporadic cases (Mivoshi et al. 1992 : Powell et al. 1992 : Mivaki et al. 1994 . This indicates that the suppression of APC activity is a key step in early phases of colorectal carcinogenesis. Although somatic mutations are dispersed along the entire coding region of APC. more than 80%7-of them are clustered between codons 1281 and 1554.
The complete inactivation of the APC gene. through the mutation or the loss of the constitutionally w ild-tx pe allele. was found to be necessarv for the development of desmoid tumours that occur in FAP patients (Mixvaki et al. 1993 : Sen-Gupta et al. 1993 : Palmirotta et al. 1995 . Also. in these tumours the somatic mutations were found to cluster in a restricted region of APC (codons 1399-1584). The involvement of APC in non FAP-related desmoids also is indirectly suggested bx the finding of deletions affectingc chromosome Sq in a subgroup of these tumours (Bnrdce et al. 1992 (Bnrdce et al. . 1996 . More recently. Alman et al (I1997b) reported the identification of APC mutations in three of six sporadic aggressive fibromatoses analvsed in exon 15.
In this stud. v-e screened the entire coding sequence of APC in desmoid tumours from patients both with and without FAP in order to investigate the occurrence in the two groups of a possible common molecular mechanism. (Pensotti et al. 1997 ). Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis was carried out using the primers and amplification conditions reported by Groden et al (1991) . PCR products were heat denatured. loaded on 20% homogeneous Phast-gels (Pharmacia Biotech). run on a Phast System1" apparatus under non-denaturing conditions and visualized by silver staining. In vitro synthesized-protein (IVSP) assay was performed as described elsewhere (Powell et al. 1993 . PCR products were examined using a Phast SystemT`' apparatus as described above.
RESULTS
The APC gene was investigated in the 20 desmoid tumours included in the study by a combination of two methods (Figure 1) . In all cases both germline alleles were found to be maintained in the corresponding tumour DNAs. Two intragenic polymorphisms. one in exon 11 (Groden et al. 1991) . and one in exon 13 (Fodde et al. 1992) were also analysed by SSCP. Two patients. one with FAP (no. 2444) and one sporadic (no. 2324). were informative for both polymorphisms and maintained heterozygosity in tumour DNA. whereas the other six cases were constitutionally homozygous for both polymorphisms (data not shown).
DISCUSSION
The screening of the APC gene in FAP-and non-FAP-related desmoid tumours revealed substantial differences between the two groups. Germline APC mutations were identified in all four FAP patients. In contrast. no constitutional abnormalities of the gene were found in sporadic desmoids. It has been reported recently that germline APC mutations are responsible for an inheritable form of susceptibility to desmoids. which may occur in individuals that do not carry the high number of colonic polyps (>100) characteristic of FAP (Eccles et al. 1996 : Scott et al. 1996 . However. our results suggest that the majority of desmoid tumours that arise in patients without evidence of FAP are not due to constitutional defects in the APC gene.
At the somatic level. APC mutations were found in desmoids both from FAP patients and sporadic cases. but at significantly different frequencies. Three of the four FAP-associated desmoids (75%) carried somatic mutations predicted to lead to the truncation of APC protein products. Although not formally demonstrated. it Briish Journal of Cancer (1998) 78(5) Low APC mutation rate in sporadic desmoids 585 is likely that these mutations affected the constitutionally w-ildtype alleles. thus leading to the complete inactivation of APC. as documented in previous studies (Mivaki et al. 1993 : Sen-Gupta et al. 1993 : Palmirotta et al. 1995 . On the other hand. truncating APC mutations were observed in onlv 2 of the 16 sporadic cases (12.5%). a proportion significantly lower than in FAP patients (P = 0.03. Fisher's exact test). and only in one of these did we detect the inactivation of both alleles. The fraction of mutated sporadic desmoids observed in this study was lower than that reported by Alman et al (1997b) . who identified APC mutations in three of six cases (50% ). However. this difference was not significant (P = 0.10. Fisher's exact test).
and might be caused by a sampling bias. It seems unlikely that the low rate of APC mutations detected in sporadic cases. in comparison with FAP-related ones. is attributable to a reduced sensitivity of the screening protocol employed. as both groups were analysed using the same approach. However.
it cannot be excluded. at least in theory. that sporadic desmoids carrv APC mutations that tie preferentially in those regions of the gene that were not analvsed in this study. including regulatory sequences. It is also possible that in sporadic desmoids the APC gene is affected by mutations that are not detectable bv the techniques that were used. For example. missense mutations in exonic regions that xWere analy sed only by IVSP xould has-e been missed. as this method only detects nonsense and frameshift mutations. These possibilities. however. would be in contrast with previous observations. which suggest that the development of desmoids mediated by the APC gene requires the presence of at least one allele carrying a truncating mutation near or bevond codon 1444 (Palmirotta et al. 1995 (Bridge et al. 1992 (Bridge et al. . 1996 . should also be considered. Unfortunately. this could not be adequately examined in this studv. as the search for allele losses affecting APC could be performed only in four of the sporadic tumours. All were found to be heterozygous for the flankingc markers D5S346. but only one case. no. 2324 with somatic mutations in both APC alleles. was informative for the two intragenic polymorphisms investigated.
Even considering the above-mentioned technical limitations. control cell to cell adhesion and cell rmigration (Nathke et al. 1996 : Barth et al. 1997 (Schnitzler et al. 1996) . and it has been suggested that this effect might explain, at least in part. the growth inhibition properties of the drug. If this were true. one should expect that sulindac has no or little effect in inducing the regression of desmoids that do not express wild-type APC protein. However, no data are at present available to confirm this hypothesis.
Finally, it must be noted that the tmo sporadic desmoids in which mutations of APC were detected were also the only two non FAP-related tumours that occurred in the abdominal wall.
Interestinglv. 10 out of the 15 FAP-associated desmoids that have been reported to carry somatic APC mutations were also localized in the abdominal wall (Mivaki et al. 1993 : Sen-Gupta et al. 1993 : Palmiirotta et al. 1995 . This might suggest that the presence of somatic APC mutations in desmoid DNA. rather than being dependent on the germline status of the patients.
reflects the anatomical site of tumour appearance. However. somatic mutations of APC were also reported in FAP-related desmoids that originated intra-abdominally (Mivak-i et al. 1993 and present study), which is by far the most frequent site of occurrence of desmoids in FAP patients (Jones et al. 1986 : Gurbuz et al. 1994 . but not in the two intra-abdominal sporadic cases (no. 2429 and 2442) analysed in this study.
